D. Price

Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.

D. Bostwick, M. Steiner, B. Stein, 2006, The Journal of urology.

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study.

M. Steiner, S. Malkowicz, P. Sieber, 2008, The Journal of urology.

Toremifene citrate versus placebo for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer.

M. Steiner, R. Israeli, D. Price, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

690: Toremifene for the Prevention of Prostate Cancer Among 514 Men with High-Grade Prostatic Intraepithelial Neoplasia (PIN): Results of a Double-Blind, Placebo-Controlled Phase IIB Trial

D. Bostwick, M. Steiner, B. Stein, 2005 .

Double-blind, placebo-controlled trial of toremifene for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia

D. Bostwick, M. Steiner, B. Stein, 2005 .